- Home
- ITGR vs HTFL Comparison
ITGR vs HTFL Comparison
Compare ITGR & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ITGR | HTFL |
|---|---|---|
| Founded | 1970 | 2007 |
| Country | United States | United States |
| Employees | N/A | 843 |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 2.5B |
| IPO Year | 2000 | N/A |
Fundamental Metrics
Financial Performance| Metric | ITGR | HTFL |
|---|---|---|
| Price | $93.68 | $26.72 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 5 |
| Target Price | ★ $91.14 | $38.20 |
| AVG Volume (30 Days) | 424.4K | ★ 2.1M |
| Earning Date | 04-30-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.48 | N/A |
| Revenue | ★ $1,853,637,000.00 | N/A |
| Revenue This Year | $1.69 | $27.66 |
| Revenue Next Year | $6.53 | $23.55 |
| P/E Ratio | $191.56 | ★ N/A |
| Revenue Growth | ★ 7.98 | N/A |
| 52 Week Low | $62.00 | $20.13 |
| 52 Week High | $120.41 | $41.22 |
Technical Indicators
Market Signals| Indicator | ITGR | HTFL |
|---|---|---|
| Relative Strength Index (RSI) | 55.89 | 39.35 |
| Support Level | $82.58 | $24.77 |
| Resistance Level | $95.48 | $32.69 |
| Average True Range (ATR) | 2.60 | 2.33 |
| MACD | -0.09 | -0.82 |
| Stochastic Oscillator | 73.19 | 8.73 |
Price Performance
Historical ComparisonAbout ITGR Integer Holdings Corporation
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns maximum of its revenue in the United States, and also has its presence in Ireland, Puerto Rico, Costa Rica, and Rest of the World.
About HTFL Heartflow Inc.
HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.